Status: current, Defined. Date: 28-Feb 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4784141000168113 | Olamlo HCT 20/5/12.5 (amlodipine 5 mg + hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 30 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4784151000168110 | Olamlo HCT 20/5/12.5 tablet, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Olamlo HCT 20/5/12.5 tablet, 30 | Is a | olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 | true | Inferred relationship | Some | ||
| Olamlo HCT 20/5/12.5 tablet, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Olamlo HCT 20/5/12.5 tablet, 30 | has TP | Olamlo HCT 20/5/12.5 | true | Inferred relationship | Some | ||
| Olamlo HCT 20/5/12.5 tablet, 30 | has TPUU | Olamlo HCT 20/5/12.5 tablet | true | Inferred relationship | Some | 1834729676 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Olamlo HCT 20/5/12.5 tablet, 30, blister pack | Is a | True | Olamlo HCT 20/5/12.5 tablet, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR